December 10, 2020

Effective treatments that reduce the risk factors associated with ASCVD offers tremendous value to the patient community.

Read the Letter

Tags: Cardiovascular, Cost Value

Categorized in: Analysis

Recent Blog Posts

Why Don’t Insurers Take Obesity Seriously? June 30, 2022

Feds Poised to Take a Hard Look at Pharmacy Benefit Managers June 28, 2022

Federal Court Upholds West Virginia Law that Reigns in “Bad Drug” Ads June 24, 2022